GNVR insider receives 200,000 shares in stock awards
By AlphaYouPublished Form 4
Yates Clayton Clopton
Reporting filer
Yates Clayton Clopton reported 200,000 shares of Common Stock in Genvor Inc as grants or awards dated 2026-04-15. The Form 4 was disclosed on Nov 3, 2026. These were stock awards, not open-market purchases.
- Disclosed
- Nov 3, 2026
Reported details
1 entry| Security | Owner | Date | Code | Action | Quantity | Price | Following holdings | Reporting delay | Filed terms and references |
|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Yates Clayton Clopton | 2026-04-15 | A | Grant or award | 200000 | 0.50 | 600,000 | 202 days | Filed terms
|
Common Stock
- Owner
- Yates Clayton Clopton
- Date
- 2026-04-15
- Code
- A
- Action
- Grant or award
- Quantity
- 200000
- Price
- 0.50
- Following holdings
- 600,000
- Reporting delay
- 202 days
- Filed terms and references
Filed terms
- security Title: Common Stock
- transaction Date: 2026-04-15
- deemed Execution Date:
- transaction Form Type: 4
- transaction Code: A
- equity Swap Involved: 0
- transaction Timeliness:
- transaction Shares: 200000
- transaction Price Per Share: 0.50
- id: F1
- transaction Acquired Disposed Code: A
- shares Owned Following Transaction: 600000
- direct Or Indirect Ownership: I
- nature Of Ownership: ACT Holdings, LLC
- id: F2
Purchases, sales, grants and option exercises are different transactions. The reported code identifies the action; it does not establish a motive.
Filing context
- Quantities and prices are shown in the units filed. No trade value is inferred from their product.
- Yates Clayton Clopton: Director, 10% owner.
- F1: Shares issued upon Dr. Yates' conversion of $100,000 in outstanding payables owed by the Company to Dr. Yates, pursuant to his scientific advisor agreement with the Company and the Company's restructured compensation package previously approved by the Company, which permits Dr. Yates to convert amounts due to him into Company common stock.
- F2: Dr. Yates has voting and dispositive power with respect to shares held in the name of ACT Holdings, LLC, and is therefore deemed to be beneficial owner of shares held in its name.
Original sources
Prepared automatically from public filing data. Report a correction.